Exact Mass: 282.12022360000003
Exact Mass Matches: 282.12022360000003
Found 500 metabolites which its exact mass value is equals to given mass value 282.12022360000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Hydroxynevirapine
2-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 2-Hydroxynevirapine is a metabolite of Nevirapine. 2-hydroxynevirapine belongs to the family of Pyridinones. These are compounds containing a pyridine ring, which bears a ketone.
2-Aminoadenosine
2-Aminoadenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
Dehydrocoformycin
A coformycin derivative in which the hydroxy group on the diazepine ring of coformycin is replaced by an oxo group.
Threonyltyrosine
Threonyltyrosine is a dipeptide composed of threonine and tyrosine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Tyrosyl-Threonine
Tyrosyl-Threonine is a dipeptide composed of tyrosine and threonine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
N1-methylinosine
1-methylinosine is inosine carrying a methyl substituent at position 1 on the hypoxanthine ring. It has a role as a metabolite. It derives from an inosine. It is a modified nucleotide found at position 37 in tRNA 3 to the anticodon of eukaryotic tRNA. Shown that sequences are forced to adopt a hairpin conformation if one of the central 6 nt is replaced by the corresponding methylated nucleotide, such as 1-methylguanosine. In Vivo synthesis: Inosine-37 in tRNA is synthesised by a hydrolytic deamination-type reaction, catalysed by distinct tRNA:adenosine deaminases. Modified nucleotide found at position 37 in tRNA 3 to the anticodon of eukaryotic tRNA. Shown that sequences are forced to adopt a hairpin conformation if one of the central 6 nt is replaced by the corresponding methylated nucleotide, such as 1-methylguanosine. 1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA[1]. 1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA[1].
12-Hydroxynevirapine
12-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 12-Hydroxynevirapine is a metabolite of Nevirapine. 12-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.
8-Hydroxynevirapine
8-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 8-Hydroxynevirapine is a metabolite of Nevirapine. 8-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.
3-Hydroxynevirapine
3-Hydroxynevirapine is only found in individuals that have used or taken Nevirapine. 3-Hydroxynevirapine is a metabolite of Nevirapine. 3-hydroxynevirapine belongs to the family of 1,4-Diazepines. These are organic compounds containing 1,4-diazepine, a seven-member heterocyclic ring with two nitrogen atoms in positions 1 and 4.
Isoeugenol phenylacetate
Isoeugenol phenylacetate is a flavouring ingredient. Flavouring ingredient
Hydroxy-lacosamide
Hydroxy-lacosamide is a metabolite of lacosamide. Lacosamide (formerly known as erlosamide) is a medication developed by UCB for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain marketed under the trade name Vimpat. The U.S. Food and Drug Administration accepted UCBs New Drug Application for lacosamide as of November 29, 2007, beginning the approval process for the drug. (Wikipedia)
3-(2-(Benzoxazol-2-yl)ethyl)-5-ethyl-6-methylpyridin-2(1H)-one
2H-1-Benzopyran-2-carboxylic acid, 3,4-dihydro-6-phenyl-, ethyl ester
3-(Hydroxymethyl)-5,5-diphenylimidazolidine-2,4-dione
C16H14N2O3 (282.10043740000003)
4-Hydroxyequilenin
bendazac
C16H14N2O3 (282.10043740000003)
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
2-{2-[3-(2-Carbamimidoylsulfanyl-ethyl)-phenyl]-ethyl}-isothiourea
S,S'-(1,4-Phenylene-bis(1,2-ethanediyl))bis-isothiourea
2,3-Dihydro-6-(3-(2-hydroxymethyl)phenyl-2-propenyl)-benzofuranol
Obovatol
Obovatol is a natural product found in Magnolia garrettii, Magnolia chevalieri, and other organisms with data available. Obovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb[1]. Obovatol is a biphenyl ether lignan isolated from the leaves of Magnolia obovata Thunb[1].
Multiplolide B
A 10-membered lactone obtained from 10-methyl-9,10-dihydro-2H-oxecin-2-one by the epoxidation of the double bond at position 3-4 and cis-dihydroxylation of the double bond at position 7-8, with further acylation of the hydroxy group at position 8 by a but-2-enoyl group. Multiplolide B was first isolated from the fungus Xylaria multiplex BCC 1111. It shows antifungal activity against Candida albicans. The epoxide group has cis-configuration, but its configuration relative to the other substituents was not established.
1-Methyl-2-(4-methoxybenzyl)-1,2,3,4-tetrahydroquinazoline-4-one
2,8-Dihydroxy-1,7-dimethyl-6-vinyl-10,11-dihydrodibenz[b,f]oxepin
(3R)-3-(beta-D-glucopyranosyloxy)-4-hydroxybutanoic acid
3-(3-chloro-2-hydroxypropyl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
C14H19ClN2O2 (282.11349839999997)
1-(3-Methylbutanoyl)-(E)-3-Tridecene-5,7,9,11-tetrayne-1,2-diol|1-isovaleryloxy-tridec-3E-en-5,7,9,11-tetrayn-2-ol
3-O-alpha-D-xylopyranosyl-L-arabinose|O3-alpha-D-Xylopyranosyl-L-arabinose
1,2-Dihydro-(Z,Z)-1,12-Diisothiocyanato-1,11-dodecadiene
2,3-Dihydroxymethyl-4-(3,4-dimethoxyphenyl)-??-butyrolactone
5-O-alpha-L-Arabinofuranosyl-L-arabinose|O5-alpha-L-Arabinofuranosyl-arabinose
(6R,12R,14R)-(3E,9E)-12-hydroxy-6,14-dimethyl-1,7-dioxacyclotetradeca-3,9-diene-2,8,11-trione|11-Ketonee-Colletodiol|6R,12R,14R-colletoketol|colletoketol|grahamimycin A|Grahamimycin A1
(2S,3S)-2,3-dihydro-3-hydroxymethyl-2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran
A member of the class of benzofurans that is 2,3-dihydro-1-benzofuran substituted by a hydroxymethyl group at position 3, a prop-1-en-1-yl group at position 5 and a 4-hydroxyphenyl group at position 2. It is a lignan derivative isolated from the roots of Krameria lappacea.
5-hydroxymethyl-9-methoxycanthin-6-one
C16H14N2O3 (282.10043740000003)
Phenol, 2-[3-hydroxy-4-(2-propenyl)phenoxy]-5-(2-propenyl)-
(Z)-2-(4-hydroxyphenyl)ethenyl-alpha-L-rhamnopyranoside
4-<3-Hydroxy-2,2-bis(hydroxymethyl)propyloxy>-5,5-bis(hydroxymethyl)-1,3-dioxan
2-deoxy-4-O-alpha-D-galactopyranosyl-D-glycero-tetronic acid
4-hydroxy-alpha-[4-((E)-1-propenyl)phenoxy]propiophenone
(3S*,4S*)-3,4-dihydro-3,4,8-trihydroxy-6-methoxy-7-(1-methoxyethyl)naphthalen-1(2H)-one|botryosphaerone C
(7S,7S,8R)-8(9)-ene-4,4-dihydroxy-7,7-epoxylignan|ribesin C
6-hydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-3,7-dioxabicyclo-[3.3.0]-octane
2-(4-hydroxyphenyl)-5-(3-hydroxypropyl)-3-methylbenzofuran|Olmecol
(2R,3R)-2,3-dihydro-2-(4-hydroxyphenyl)-3-methyl-5-(2-oxopropyl)benzofuran|miliumollinone
alpha-(3-Chloro-1-propenyl)-6-(2-penten-4-ynyl)-2,5-dioxabicyclo[2,2,1]heptane-3-ethanol
C15H19ClO3 (282.10226539999996)
(-)-grahamimycin A1|(R,R)-(-)-Grahamimycin A1|grahamimycin|Grahamimycin A1
3-O-alpha-D-galactopyranosyl-2-C-methylglyceric acid
(E)-4,5,6,7-tetrahydroxy-2-benzylhept-2-enoic acid|drypearmoracein A
R-2-(4-hydroxyphenyl)-5-(2-hydroxypropyl)-3-methylbenzofuran|S-2-(4-hydroxyphenyl)-5-(2-hydroxypropyl)-3-methylbenzofuran
1,4-Di Me ether,di-Ac-3,6-Dimethyl-1,2,4,5-benzenetetrol
Ac-(all-E)-10-(4-Hydroxyphenyl)-3,5,7,9-decatetraen-2-one
(3R*,4R*)-3,4-dihydro-3,4,8-trihydroxy-3-(2-hydroxypropyl)-6-methoxynaphthalen-1(2H)-one|balticol E
Succinic acid 1-butyl 4-(5-formyl-2-furylmethyl) ester
Di-Me ether,Me ester-1,3-Dihydro-3,7-dihydroxy-5-methoxy-6-methyl-4-isobenzofurancarboxylic acid
2-Me ether-9,10-Dihydro-2,7-dihydroxy-1,8-dimethyl-4-phenanthrenecarboxaldehyde|5-formyl-2-hydroxy-1,8-dimethyl-7-methoxy-9,10-dihydrophenanthrene
Isomaglone
Isomagnolone is a natural product found in Illicium simonsii with data available.
Methyl 4,6-O-benzylidene-α-D-glucopyranoside
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.717 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.718
4-[5-(4-hydroxyphenyl)-3,4-dimethyl-2,5-dihydrofuran-2-yl]phenol
C11H14N4O5_6H-Purin-6-one, 1,9-dihydro-9-(3-O-methylpentofuranosyl)
C14H18O6_Heptonic acid, 4,7-anhydro-2-deoxy-7-C-phenyl-, methyl ester
2-O-Methylinosine
Inosine carrying a methyl substituent on the hydroxy group at position 2 on the ribose ring. 9-((2R,3R,4R,5R)-4-Hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-9H-purin-6-ol (2'-O-methylinosine) is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
methyl 3-(3,4-dihydroxy-5-phenyloxolan-2-yl)-3-hydroxypropanoate
Di(2-methoxyethyl) phthalate
CONFIDENCE standard compound; INTERNAL_ID 397; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7846; ORIGINAL_PRECURSOR_SCAN_NO 7843 CONFIDENCE standard compound; INTERNAL_ID 397; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7826; ORIGINAL_PRECURSOR_SCAN_NO 7822 CONFIDENCE standard compound; INTERNAL_ID 397; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7851; ORIGINAL_PRECURSOR_SCAN_NO 7849
methyl 3-(3,4-dihydroxy-5-phenyloxolan-2-yl)-3-hydroxypropanoate_0.5\\%
methyl 3-(3,4-dihydroxy-5-phenyloxolan-2-yl)-3-hydroxypropanoate_major
1-Methylinosine
Inosine carrying a methyl substituent at position 1 on the hypoxanthine ring. 1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA[1]. 1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA[1].
12-Hydroxynevirapine
A dipyridodiazepine that is nevirapine in which one of the hydrogens of the methyl group has been substituted by a hydroxy group. It is a metabolite of the anti-HIV drug, nevirapine.
2-Hydroxynevirapine
8-Hydroxynevirapine
3-Hydroxynevirapine
THR-Tyr
A dipeptide composed of L-threonine and L-tyrosine joined by a peptide linkage.
Arabinofuranobiose
Uracil,1,3-dimethyl-5,6-bis(N-methylacetamido)- (6CI)
Erteberel
C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent C147908 - Hormone Therapy Agent
bis(2,3-epoxypropyl) cyclohex-4-ene-1,2-dicarboxylate
METHYL 7-(BENZYLOXY)-1H-INDAZOLE-3-CARBOXYLATE
C16H14N2O3 (282.10043740000003)
Methyl 5-(benzyloxy)-1H-indazole-3-carboxylate
C16H14N2O3 (282.10043740000003)
(7R,9AR)-TERT-BUTYL7-(AMINOMETHYL)HEXAHYDRO-1H-PYRIDO[1,2-A]PYRAZINE-2(6H)-CARBOXYLATE
C16H14N2O3 (282.10043740000003)
Trimethylsilyl p-(trimethylsilyloxy)benzoate
7-(benzyloxy)-6-methoxyquinazolin-4-ol
C16H14N2O3 (282.10043740000003)
TRANS-3,4-DIFLUOROPHENYL 4-PROPYLCYCLOHEXANECARBOXYLATE
4-(4-METHYLPIPERAZIN-1-YL)-3-(METHYLSULFONYL)BENZALDEHYDE
(Z)-(2,4-Difluorophenyl)(piperidin-4-yl)methanone O-acetyl oxime
METHYL 3-(TERT-BUTOXYCARBONYLAMINO)-2-METHOXYISONICOTINATE
tert-butyl 2-chloro-5,6,7,8-tetrahydropyrido[2,3-b]azepine-9-carboxylate
C14H19ClN2O2 (282.11349839999997)
2-(PIPERIDIN-1-YLCARBONYL)-3,4-DIHYDRO-2H-1,4-BENZOXAZINE HYDROCHLORIDE
C14H19ClN2O2 (282.11349839999997)
1-[(4-tert-butylphenyl)sulfonyl]piperazine(SALTDATA: FREE)
2-[(2-CARBOMETHOXYPHENOXY)METHYL]-BENZIMIDAZOLE
C16H14N2O3 (282.10043740000003)
5(6)-carbethoxy-2-(4-hydroxyphenyl)-benzimidazole
C16H14N2O3 (282.10043740000003)
1,1,3,3-Tetraethoxy-1,3-dimethyldisiloxane
C10H26O5Si2 (282.13187059999996)
2-(4-AMino-2-ethoxyphenyl)pthaliMide
C16H14N2O3 (282.10043740000003)
4-Boc-9-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
C14H19ClN2O2 (282.11349839999997)
4-Boc-8-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
C14H19ClN2O2 (282.11349839999997)
4-Boc-7-Chloro-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
C14H19ClN2O2 (282.11349839999997)
3-(Methylsulfonyl)phenylboronic Acid Pinacol Ester
[4-[Bis(2-hydroxyethyl)amino]phenyl]-1,1,2-ethylenetricarbonitrile
4-(4-METHYLPIPERAZIN-1-YL)-2-(METHYLSULFONYL)BENZALDEHYDE
Methyl 6-(benzyloxy)-1H-indazole-3-carboxylate
C16H14N2O3 (282.10043740000003)
tert-butyl N-[2-hydroxy-2-(4-nitrophenyl)ethyl]carbamate
2-Chloro-3-((trimethylsilyl)ethynyl)pyridin-4-amine
TRIMETHYLSILYL TRIMETHYLSILOXY SALICYLATE
Ethyl 4-[[(methylphenylamino)methylene]amino]benzoate
Ethyl 2-((2-((tert-butoxycarbonyl)amino)ethyl)amino)acetate hydrochloride
ETHYL 2-CHLORO-2-[2-(4-TERT-BUTYLPHENYL)HYDRAZONO] ACETATE
C14H19ClN2O2 (282.11349839999997)
a-D-Mannopyranoside, methyl4,6-O-(phenylmethylene)-
Ethyl 4-(1,3-benzoxazol-2-ylamino)benzoate
C16H14N2O3 (282.10043740000003)
1-(IMINO-PIPERIDIN-1-YL-METHYL)-3-PHENYL-UREA HYDROCHLORIDE
(1-BENZYL-1H-IMIDAZOL-2-YL)METHANOL
C16H14N2O3 (282.10043740000003)
4,4,5,5-TETRAMETHYL-2-(4-(METHYLSULFONYL)PHENYL)-1,3,2-DIOXABOROLANE
2-(3-FORMYL-INDOL-1-YL)-N-FURAN-2-YLMETHYL-ACETAMIDE
C16H14N2O3 (282.10043740000003)
(2-Methyl sulfonyl penyl)boronic acid pinacol ester
2-(3-CHLORO-5-ETHOXYPHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
C14H20BClO3 (282.11939500000005)
Methyl 4-(benzyloxy)pyrazolo[1,5-a]pyridine-3-carboxylate
C16H14N2O3 (282.10043740000003)
METHYL 1-(2-ETHOXYETHYL)-4,5,6,7-TETRAHYDRO-5,7-DIOXO-1H-PYRAZOLO[4,3-D]PYRIMIDINE-3-CARBOXYLATE
3-oxo-3-(2,3,4-trimethoxyphenyl)propionic acid ethyl ester
8-Aminoadenosine
8-Aminoadenosine (8-NH2-Ado), a RNA-directed nucleoside analogue, reduces cellular ATP levels and inhibits mRNA synthesis. 8-Aminoadenosine blocks Akt/mTOR signaling and induces autophagy and apoptosis in a p53-independent manner. 8-Aminoadenosine has antitumor activity[1][2][3]. 8-Aminoadenosine (8-NH2-Ado), a RNA-directed nucleoside analogue, reduces cellular ATP levels and inhibits mRNA synthesis. 8-Aminoadenosine blocks Akt/mTOR signaling and induces autophagy and apoptosis in a p53-independent manner. 8-Aminoadenosine has antitumor activity[1][2][3].
2-Propenoic acid, 3-[2-methyl-4-(phenylmethoxy)phenyl]-, methyl ester
5-(4-methoxyphenyl)-5-phenylimidazolidine-2,4-dione
C16H14N2O3 (282.10043740000003)
4-(4-fluorophenyl)-6-propan-2-yl-1H-pyrrolo[2,3-b]pyridine-5-carbaldehyde
C17H15FN2O (282.11683519999997)
1,3,4-Oxadiazole,2,5-bis(3-methoxyphenyl)-
C16H14N2O3 (282.10043740000003)
Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-3-carboxylate
2-(4-Methylpiperazin-1-yl)-4-(methylsulfonyl)benzaldehyde
ETHYL 6,6-DIMETHYL-3-HYDRAZINO-4-OXO-4,5,6,7-TETRAHYDROBENZO(C)THIOPHENE-1-CARBOXYLATE, TECH.
7-methoxy-6-phenylmethoxy-1H-quinazolin-4-one
C16H14N2O3 (282.10043740000003)
1-(3-Nitro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone
C16H14N2O3 (282.10043740000003)
1H-Pyrrolo[2,3-b]pyridine-5-carboxylicacid,1-[(4-Methoxyphenyl)Methyl]-
C16H14N2O3 (282.10043740000003)
1-ethyl-3-methylimidazol-3-ium,4-methylbenzenesulfonate
5-TERT-BUTYL 2-METHYL 6,7-DIHYDROOXAZOLO[5,4-C]PYRIDINE-2,5(4H)-DICARBOXYLATE
N-(4-methoxybenzyl)-3-(trifluoromethyl)pyridin-2-amine
METHYL 5-(BENZYLOXY)PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLATE
C16H14N2O3 (282.10043740000003)
4-[6-(2-Fluoroethoxy)-2-quinolinyl]aniline
C17H15FN2O (282.11683519999997)
Methyl alpha-D-ribofuranoside 5-(4-methylbenzoate)
(E)-4-((3-(pyridin-3-yl)acrylaMido)Methyl)benzoic acid
C16H14N2O3 (282.10043740000003)
METHYL 5-OXO-2,3,5,6-TETRAHYDRO-1H-INDOLIZINO[6,7-B]INDOLE-11-CARBOXYLATE
C16H14N2O3 (282.10043740000003)
methyl 5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate
4-(2-Chloro-ethoxy)-phenyl-4,4,5,5-tetramethyl-1,3,2dioxaborolane
C14H20BClO3 (282.11939500000005)
Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carboxylate
2-Chloro-1-[[2-(triMethylsilanyl)ethoxy]Methyl]-benzimidazole
C13H19ClN2OSi (282.09551139999996)
3-benzyl-7,7-dimethyl-6,8-dihydrochromene-2,5-dione
Methyl-4-(4-chloro-1-oxobutyl)-alpha
C15H19ClO3 (282.10226539999996)
2-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyridine-3-carbaldehyde
C16H14N2O3 (282.10043740000003)
2-Fluoro-4,5-dimethoxyphenylboronic acid,pinacol ester
C14H20BFO4 (282.14386020000006)
2-(2-(2-CHLOROETHOXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE
C14H20BClO3 (282.11939500000005)
(2-(((5,6,7,8-TETRAHYDRONAPHTHALEN-1-YL)OXY)METHYL)PHENYL)BORONIC ACID
C17H19BO3 (282.14271740000004)
1-[2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]ethanol
C14H20BClO3 (282.11939500000005)
4-(3-Thienylmethyl)-1-piperazinecarboxylic acid 1,1-dimethylethyl ester
N-cyclopropyl-2-piperazin-1-ylpyridine-3-carboxamide,hydrochloride
Diethyl 2,5-dioxobicyclo[2.2.2]octane-1,4-dicarboxylate
Benzenepropanoic acid, b-oxo-a-(phenylmethyl)-, ethyl ester
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methyl-alanine ethyl ester
C14H19FN2O3 (282.13796360000003)
1-{2-Oxo-3-[(1r)-1-(1h-Pyrrol-2-Yl)ethyl]-2h-Indol-5-Yl}urea
2,3-Dihydro-6-(3-(2-(hydroxymethyl)phenyl)-2-propen-1-yl)-5-benzofuranol
2,6-Piperazinedione, 4,4-(1,2-dimethyl-1,2-ethanediyl)bis-, rel-
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines D004791 - Enzyme Inhibitors
6-O-Methylinosine
Inosine carrying a methyl substituent on the oxygen at position 6 on the hypoxanthine ring.
N-[4-(4-oxo-2,3-dihydro-1,3-benzoxazin-2-yl)phenyl]acetamide
C16H14N2O3 (282.10043740000003)
N-[(4-nitrophenyl)methyl]-1,2,3,4-tetrahydronaphthalen-1-amine
Benzyl 3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate
C16H14N2O3 (282.10043740000003)
3-(2-oxo-1,3-benzoxazol-3-yl)-N-phenylpropanamide
C16H14N2O3 (282.10043740000003)
Ethyl 4-methyl-7-phenylpyrazolo[5,1-c][1,2,4]triazine-3-carboxylate
4-Morpholineacetic acid, (5-nitrofurfurylidene)hydrazide
2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamide
3-(9-Oxo-9,10-dihydroacridine-2-yl)alanine
C16H14N2O3 (282.10043740000003)
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, propyl ester
C16H14N2O3 (282.10043740000003)
1H-Pyrimido[1,2-a]quinoline-2-carboxylic acid, 1-oxo-, 1-methylethyl ester
C16H14N2O3 (282.10043740000003)
1H-Pyrimido[1,2-a]quinoline-2-acetic acid, 1-oxo-, ethyl ester
C16H14N2O3 (282.10043740000003)
3-[(4-Cyanobiphenyl-4-Yl)oxy]-N-Hydroxypropanamide
C16H14N2O3 (282.10043740000003)
(3AS,4R,9BR)-4-(4-Hydroxyphenyl)-1,2,3,3A,4,9B-hexahydrocyclopenta[C]chromen-9-OL
2-(7-Amino-6-methyl-3H-pyrazolo[4,3-D]pyrimidin-3-YL)-5-hydroxymethyl-tetrahydro-furan-3,4-diol
C11H16N5O4+ (282.12022360000003)
4-(3,4-Dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yloxy)-tetrahydro-pyran-2,3,5-triol
Bendazac
C16H14N2O3 (282.10043740000003)
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Xylobiose
Xylobiose is a glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. It has a role as a bacterial metabolite. Xylobiose is a natural product found in Streptomyces ipomoeae, Chlamydomonas reinhardtii, and Streptomyces rameus with data available. A glycosylxylose that is D-xylopyranose having a beta-D-xylopyranosyl residue attached at position 4 via a glycosidic bond. Major or sole repeating unit in the main xylan chains of the plant xylans, arabinoxylans and glucuronoxylans. Isolated from Scotch pine (Pinus sylvestris). Xylobiose (1,4-β-D-Xylobiose; 1,4-D-Xylobiose) is a disaccharide?of?xylose?monomers with a β-1, 4 bond between monomers[1].
4-[5-(4-Hydroxyphenyl)-3,4-dimethyl-2,5-dihydrofuran-2-yl]phenol
N-(4-fluorophenyl)-N-hydroxyoctanediamide
C14H19FN2O3 (282.13796360000003)
5-(3,5-Dimethoxyphenyl)-3-phenyl-1,2,4-oxadiazole
C16H14N2O3 (282.10043740000003)
N-[4-oxo-2-(2-pyridinyl)-1,2-dihydroquinazolin-3-yl]acetamide
N-(3,4-dimethylphenyl)-5-(2-furanyl)-3-isoxazolecarboxamide
C16H14N2O3 (282.10043740000003)
3-(2-Ethoxy-6-methyl-3-pyridinyl)-5-(2-pyridinyl)-1,2,4-oxadiazole
N-[(E)-1,3-benzodioxol-5-ylmethylideneamino]-2-phenylacetamide
C16H14N2O3 (282.10043740000003)
2-(2-Furanyl)-3,5-dimethyl-4-oxido-6-phenylpyrazin-1-ium 1-oxide
C16H14N2O3 (282.10043740000003)
1-[2-(2,5-Dimethylpyrrol-1-yl)-4-nitrophenyl]imidazole
5-methyl-N-(5-methyl-2-phenyl-3-pyrazolyl)-3-isoxazolecarboxamide
N-(3-carbamoyl-5-propyl-2-thiophenyl)-2-oxolanecarboxamide
N-(4-ethylphenyl)-5-(2-furanyl)-3-isoxazolecarboxamide
C16H14N2O3 (282.10043740000003)
1-(3,4-Dihydroxyphenyl)-2-(2-methyl-1-benzimidazolyl)ethanone
C16H14N2O3 (282.10043740000003)
3-[(E)-3-anilino-3-oxoprop-1-enyl]-N-hydroxybenzamide
C16H14N2O3 (282.10043740000003)
2-(4-Morpholinyl)-10-pyridazino[6,1-b]quinazolinone
N-cyano-N-[2-(trifluoromethyl)phenyl]pyrrolidine-1-carboximidamide
(2S,3R,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
C17H15FN2O (282.11683519999997)
(2S,3R,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C17H15FN2O (282.11683519999997)
(2R,3S,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)azetidine-2-carbonitrile
C17H15FN2O (282.11683519999997)
(2R,3R,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C17H15FN2O (282.11683519999997)
(2R,3R,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C17H15FN2O (282.11683519999997)
(2R,3S,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C17H15FN2O (282.11683519999997)
(2S,3S,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinecarbonitrile
C17H15FN2O (282.11683519999997)
2-[3-[(3,3-Dimethyloxiran-2-yl)methyl]-4,6-dihydroxy-2-methoxyphenyl]acetic acid
(2R)-2-amino-5-[2-(3,4-dihydroxyphenyl)ethylamino]-5-oxopentanoic acid
4-[[2-Amino-3-(3,4-dihydroxyphenyl)-1-oxopropyl]amino]butanoic acid
9-[(2R,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-1H-purin-6-one
3-carboxy-4-methyl-5-(4-oxopentyl)-2-furanpropanoic acid
3'-Azido-3'-deoxy-5-methylcytidine
3'-Azido-3'-deoxy-5-methylcytidine (CS-92) is a potent xenotropic murine leukemia-related retrovirus (XMRV) inhibitor with a CC50 of 43.5 μM in MCF-7 cells. 3'-Azido-3'-deoxy-5-methylcytidine also inhibits HIV-1 reverse transcriptase with an EC50 of 0.06 μM in peripheral blood mononuclear (PBM) cells[1]. 3'-Azido-3'-deoxy-5-methylcytidine is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.
Z26395438
C17H15FN2O (282.11683519999997)
Z26395438 (compound 1) is a potent Sirtuin-1 inhibitor, with an IC50 value of 1.6 μM[1].
(6s)-8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undec-2-ene
6-(2-hydroxy-3-methoxy-5-oxofuran-2-yl)-1,3,6-trimethyl-7-oxabicyclo[2.2.1]heptan-2-one
4-[(2s,3r)-3-(hydroxymethyl)-5-(prop-1-en-1-yl)-2,3-dihydro-1-benzofuran-2-yl]phenol
5-(3-hydroxyprop-1-en-1-yl)-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
3-(hydroxymethyl)-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one
C16H14N2O3 (282.10043740000003)
3-ethoxy-5-hydroxy-7-methoxy-4-(methoxymethyl)-6-methyl-3h-2-benzofuran-1-one
(2r,3r,4r,5r,6s)-2-{[(1z)-2-(4-hydroxyphenyl)ethenyl]oxy}-6-methyloxane-3,4,5-triol
(2r,3r,4s,5r)-4-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}oxane-2,3,5-triol
(1's,2s,3's,6'r,7'r,9'r)-6'-hydroxy-3-methoxy-3',7',9'-trimethyl-5',8'-dioxaspiro[furan-2,4'-tricyclo[4.2.1.0³,⁷]nonan]-5-one
(3s)-3-(hydroxymethyl)-13-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one
C16H14N2O3 (282.10043740000003)
methyl 4-(3-acetyl-2,6-dihydroxyphenyl)-2-methoxybutanoate
(2r,3r,4s,5s)-4-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}oxane-2,3,5-triol
[(3as,4r,10r,10as)-10-hydroxy-2,6-diimino-octahydropyrrolo[1,2-c]purin-4-yl]methyl acetate
4-hydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid
4-[5-(2-hydroxypropyl)-3-methyl-1-benzofuran-2-yl]phenol
5-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolane-2,3,4-triol
4-[(2s,3r)-3-(hydroxymethyl)-5-[(1e)-prop-1-en-1-yl]-2,3-dihydro-1-benzofuran-2-yl]phenol
2-(4-hydroxyphenyl)ethyl (3e)-4-phenylbut-3-enoate
(1s,4r,6r,7r,8e,10s)-7-hydroxy-4-methyl-2-oxo-3,11-dioxabicyclo[8.1.0]undec-8-en-6-yl (2e)-but-2-enoate
1-(3,7-dihydroxy-2,8-dimethyl-9,10-dihydrophenanthren-4-yl)ethanone
{"Ingredient_id": "HBIN001107","Ingredient_name": "1-(3,7-dihydroxy-2,8-dimethyl-9,10-dihydrophenanthren-4-yl)ethanone","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "NA","Ingredient_weight": "282.33","OB_score": "44.72290442","CAS_id": "77305-81-8","SymMap_id": "SMIT09265","TCMID_id": "NA","TCMSP_id": "MOL007912","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2,3-dihydroxymethyl-4-(3',4'-dimethoxyphenyl)-γ-butyrolactone
{"Ingredient_id": "HBIN004053","Ingredient_name": "2,3-dihydroxymethyl-4-(3',4'-dimethoxyphenyl)-\u03b3-butyrolactone","Alias": "NA","Ingredient_formula": "C14H18O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15124","TCMID_id": "6028","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4-dehydrolarreatricin
{"Ingredient_id": "HBIN007330","Ingredient_name": "3,4-dehydrolarreatricin","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "CC1=C(C(OC1C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)C","Ingredient_weight": "282.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4939","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "25775479","DrugBank_id": "NA"}
3'-hydroxy-4'-methoxy-4'-dehydroxynyasol
{"Ingredient_id": "HBIN008660","Ingredient_name": "3'-hydroxy-4'-methoxy-4'-dehydroxynyasol","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "COC1=C(C=C(C=C1)C(C=C)C=CC2=CC=C(C=C2)O)O","Ingredient_weight": "282.3 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10395","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21575014","DrugBank_id": "NA"}
3'-methoxynyasin
{"Ingredient_id": "HBIN008841","Ingredient_name": "3'-methoxynyasin","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "COC1=C(C=CC(=C1)C(C=C)C=CC2=CC=C(C=C2)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14037","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3''-methoxynyasol
{"Ingredient_id": "HBIN008842","Ingredient_name": "3''-methoxynyasol","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "COC1=C(C=CC(=C1)C(C=C)C=CC2=CC=C(C=C2)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "14038","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
7-Bromodecahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene
{"Ingredient_id": "HBIN013128","Ingredient_name": "7-Bromodecahydro-4,8,8-trimethyl-9-methylene-1,4-methanoazulene","Alias": "NA","Ingredient_formula": "C15H23Br","Ingredient_Smile": "CC1(C(CCC2(C3C1C(C2=C)CC3)C)Br)C","Ingredient_weight": "283.25","OB_score": "8.682644105","CAS_id": "24503-54-6","SymMap_id": "SMIT13506","TCMID_id": "NA","TCMSP_id": "MOL012775","TCM_ID_id": "NA","PubChem_id": "608959","DrugBank_id": "NA"}
7H-purin-3-ium-6-amine
{"Ingredient_id": "HBIN013196","Ingredient_name": "7H-purin-3-ium-6-amine","Alias": "7H-purin-3-ium-6-ylamine; 7224-92-2","Ingredient_formula": "C17H18N2O2","Ingredient_Smile": "C1=NC2=C(N1)C(=NC=[NH+]2)N","Ingredient_weight": "282.34","OB_score": "34.78964523","CAS_id": "7224-92-2","SymMap_id": "SMIT09183","TCMID_id": "NA","TCMSP_id": "MOL007817","TCM_ID_id": "NA","PubChem_id": "5231965","DrugBank_id": "NA"}
9,10-dihydro-7-hydroxy-2-methoxy-1,8-dimethyl-4-phenanthrenecarboxaldehyde
{"Ingredient_id": "HBIN013939","Ingredient_name": "9,10-dihydro-7-hydroxy-2-methoxy-1,8-dimethyl-4-phenanthrenecarboxaldehyde","Alias": "NA","Ingredient_formula": "C18H18O3","Ingredient_Smile": "NA","Ingredient_weight": "282.33","OB_score": "NA","CAS_id": "147850-87-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7303","PubChem_id": "NA","DrugBank_id": "NA"}
(6r,8s)-8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undec-2-ene
3-phenylprop-2-en-1-yl 3-hydroxy-3-phenylpropanoate
(4r,6s)-4-bromo-1,5,5,9-tetramethylspiro[5.5]undeca-1,8-diene
(3s)-4-hydroxy-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanoic acid
4-[(3r,4z)-5-(4-hydroxyphenyl)penta-1,4-dien-3-yl]-2-methoxyphenol
7-hydroxy-4-methyl-2-oxo-3,11-dioxabicyclo[8.1.0]undec-8-en-6-yl but-2-enoate
(2e,4s,5r,6s)-2-benzyl-4,5,6,7-tetrahydroxyhept-2-enoic acid
{5-[(1s)-1-hydroxyethyl]-4-methoxy-2-oxopyran-3-yl}methyl 3-methylbut-2-enoate
12,13-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one
C16H14N2O3 (282.10043740000003)
3,6,10-trimethyl-15-oxa-3,13-diazatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1,5,7,9(16),10-pentaene-4,12-dione
C16H14N2O3 (282.10043740000003)
3-hydroxy-4,4,6-trimethyl-2-(3-phenylprop-2-enoyl)cyclohexa-2,5-dien-1-one
3,4-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one
C16H14N2O3 (282.10043740000003)
2-[(3,4,5-trihydroxyoxolan-2-yl)methoxy]oxane-3,4,5-triol
(2s)-2-{[(2s,3r)-2-amino-1,3-dihydroxybutylidene]amino}-3-(4-hydroxyphenyl)propanoic acid
[5-(1-hydroxyethyl)-4-methoxy-2-oxopyran-3-yl]methyl 3-methylbut-2-enoate
2-[(4-methoxyphenyl)methyl]-1-methyl-2h-quinazolin-4-ol
(2s,3r,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2-phenylacetate
(6r,8r)-8-bromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undec-2-ene
(2r,3s,4e,7s)-7-hydroxy-2-methyl-6,10-dioxo-3,7,8,9-tetrahydro-2h-oxecin-3-yl (2e)-but-2-enoate
(2r,3r,4s,5r)-2-{[(2s,3r,4r,5r)-3,4,5-trihydroxyoxolan-2-yl]methoxy}oxane-3,4,5-triol
2-hydroxyethyl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
(3e,6s,9e,11s,14s)-11-hydroxy-6,14-dimethyl-1,7-dioxacyclotetradeca-3,9-diene-2,5,8-trione
(1r,3r,4s,6s)-6-[(2s)-2-hydroxy-3-methoxy-5-oxofuran-2-yl]-1,3,6-trimethyl-7-oxabicyclo[2.2.1]heptan-2-one
6,8-dimethoxy-3-phenyl-3,4-dihydro-2h-naphthalen-1-one
9-[(2r,3r,4s,5r)-3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-imino-3h-purin-6-ol
(2r,3r,4s)-2,3,5-trihydroxy-4-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentanal
(2s,3r,4s,5s)-2-{[(2s,3r,4r,5s)-3,4,5-trihydroxyoxolan-2-yl]methoxy}oxane-3,4,5-triol
2-phenylethyl (2e)-3-(4-methoxyphenyl)prop-2-enoate
(3s)-3-ethoxy-5-hydroxy-7-methoxy-4-(methoxymethyl)-6-methyl-3h-2-benzofuran-1-one
(1s,4r,6r,7s,8e,10s)-7-hydroxy-4-methyl-2-oxo-3,11-dioxabicyclo[8.1.0]undec-8-en-6-yl (2e)-but-2-enoate
(2r,3s,4s)-2,4,5-trihydroxy-3-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pentanal
4-bromo-1,5,5,9-tetramethylspiro[5.5]undeca-1,8-diene
4-[1-(4-hydroxyphenyl)penta-1,4-dien-3-yl]-2-methoxyphenol
2-[(4,5,6-trihydroxyoxan-3-yl)oxy]oxane-3,4,5-triol
6-(2-butyl-4-hydroxy-5-oxooxolan-2-yl)-4-methoxypyran-2-one
methyl 6-[(1r)-1-hydroxyethyl]phenazine-1-carboxylate
C16H14N2O3 (282.10043740000003)
(2e)-2-benzyl-4,5,6,7-tetrahydroxyhept-2-enoic acid
(2s,3r,4r,5s)-5-({[(2r,3r,4r,5s)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxolane-2,3,4-triol
5-[1-(4-hydroxyphenyl)penta-1,4-dien-3-yl]-2-methoxyphenol
methyl (3r)-3-[(2s,3s,4s,5r)-3,4-dihydroxy-5-phenyloxolan-2-yl]-3-hydroxypropanoate
3,4,5-trihydroxy-6-methyloxan-2-yl 2-phenylacetate
(2s,3r,4s,5s,6r)-2-(4-ethenylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
2-(4-ethenylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
(2s,3s,4r,5r)-2-(4-ethenylphenoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
7-hydroxy-2-methyl-6,10-dioxo-3,7,8,9-tetrahydro-2h-oxecin-3-yl but-2-enoate
(3s)-6,8-dimethoxy-3-phenyl-3,4-dihydro-2h-naphthalen-1-one
6-[(2r,4r)-2-butyl-4-hydroxy-5-oxooxolan-2-yl]-4-methoxypyran-2-one
2-hydroxyethyl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate
(2r,3r,4r,5r,6s)-2-{[(1e)-2-(4-hydroxyphenyl)ethenyl]oxy}-6-methyloxane-3,4,5-triol
{1-carboxy-3-[hydroxy(4-oxocyclohexa-2,5-dien-1-ylidene)methoxy]propan-2-yl}trimethylazanium
9-[3-amino-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-imino-3h-purin-6-ol
(3r,4r)-3,4-dimethoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-5,7,9(16),10(15),11,13-hexaen-2-one
C16H14N2O3 (282.10043740000003)
(2e)-3-phenylprop-2-en-1-yl (3r)-3-hydroxy-3-phenylpropanoate
(4s,6r)-4-bromo-1,5,5,9-tetramethylspiro[5.5]undeca-1,8-diene
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 2-phenylacetate
1-ethenyl-7,10a-dihydroxy-2,8-dimethyl-9,10-dihydrophenanthren-3-one
1-(2,6-dihydroxy-3,5-dimethyl-9,10-dihydrophenanthren-1-yl)ethanone
6-(1-methoxyethyl)phenazine-1-carboxylic acid
C16H14N2O3 (282.10043740000003)